Loading...
Crucell Announces STAR Research License Agreement with Celltrion, Inc.
10-Apr-2008
Advertisement
Crucell N.V. announced a non-exclusive STAR® research license agreement with Celltrion, Inc. for the production of recombinant proteins. Under the agreement, Celltrion will evaluate Crucell's STAR® technology for generating cell lines for the manufacture of biopharmaceuticals. Financial details of the agreement were not disclosed.